Renal tubular function in children with tyrosinaemia type I treated with nitisinone

Journal of Inherited Metabolic Disease

Volumn 31, Issue 3, 2008, Pages 399-402

  Santra, S ^a   Preece, M A ^a   Hulton, S A ^a   McKiernan, Pat J ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; NITISINONE; PHOSPHATE; PROTEIN; VITAMIN D;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DIET THERAPY; DISEASE COURSE; ECHOGRAPHY; FEMALE; HEREDITARY TYROSINEMIA TYPE 1; HUMAN; INFANT; KIDNEY CALCIFICATION; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE DISORDER; LIVER FAILURE; MALE; NEWBORN; PHOSPHATE BLOOD LEVEL; PRESCHOOL CHILD; PROTEIN URINE LEVEL; RENOGRAPHY; RETROSPECTIVE STUDY; RICKETS; TREATMENT DURATION; TYROSINEMIA;

CHILD; CHILD, PRESCHOOL; CYCLOHEXANONES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY; KIDNEY TUBULES; MALE; NITROBENZOATES; PROTEINURIA; RETROSPECTIVE STUDIES; TYROSINEMIAS;

EID: 45849096439     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-008-0817-x     Document Type: Article

References (16)

1. Alvares F, Bussieres J-F, Dallaire L, et al (2005) Nitisinone treatment of hepatorenal tyrosinaemia in Quebec. J Inherit Metab Dis 28 (Supplement 1): 49.
2. Forget S, Patriquin HB, Dubois J, et al (1999) The kidney in children with tyrosinaemia: Sonographic, CT and biochemical findings. Pediatr Radiol 29: 104-108.
3. Herzog D, Martin S, Turpin S, Alvarez F (2006) Normal glomerular filtration rate in long-term follow-up of children after orthotopic liver transplantation. Transplantation 81 (5): 672-677.
4. Holme E, Linstedt S (2000) Nontransplant treatment of tyrosinaemia. Clin Liver Dis 4: 805-814.
5. Kvittingen EA, Jellum E, Stokke O, et al (1986) Liver transplantation in a 23-year-old tyrosinaemia patient: Effects on the renal tubular dysfunction. J Inherit Metab Dis 9: 216-224.
6. Lindstedt S, Holme E, Lock EA, et al (1992) Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet 340: 813-817.
7. McKiernan PJ (2006) Nitisinone in the treatment of hereditary tyrosinaemia type 1. Drugs 66: 743-750.
8. Mitchell G, LaRochelle J, Lambert M, et al (1990) Neurological crises in hereditary tyrosinaemia. N Engl J Med 322: 432-437.
9. Mitchell G, Grompe M, Lambert M, Tanguay R (2001) Hypertyrosinemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 1777-1805.
10. Mohan N, McKiernan P, Preece MA, et al (1999) Indications and outcome of liver transplantation in tyrosinaemia type 1. Eur J Pediatr 158 (Supplement 2): S49-54.
11. Paradis K, Weber A, Seidman EG, et al (1990) Liver transplantation for hereditary tyrosinemia: The Quebec experience. Am J Hum Genet 47: 338.
12. Pierik LJ, van Spronsen FJ, Bijleveld CM, van Dael CM (2005) Renal function in tyrosinaemia type 1 after liver transplantation: A long-term follow-up. J Inherit Metab Dis 28: 871-876.
13. Pronicka E, Rowinska E, Bentkowski Z, et al (1996) Treatment of two children with hereditary tyrosinaemia type I and long-standing renal disease with a 4-hydroxyphenylpyruvate dioxygenase inhibitor (NTBC). J Inherit Metab Dis 19: 234-238.
14. Russo P, O'Regan S (1990) Visceral pathology of hereditary tyrosinaemia type 1. Am J Hum Genet 47: 317-324.
15. Shoemaker LR, Strife CF, Balistreri WF, Ryckman FC (1992) Rapid improvement in the renal tubular dysfunction associated with tyrosinaemia following hepatic replacement. Pediatrics 89: 251-255.
16. van Spronsen FJ, Thomasse Y, Smit GP, et al (1994) Hereditary tyrosinemia type I: A new clinical classification with difference in prognosis on dietary treatment. Hepatology 20: 1187-1191.